Structural Ties between Cholesterol Transport and Morphogen Signaling  by Bazan, J. Fernando & de Sauvage, Frederic J.
Leading Edge
CorrespondenceStructural Ties between 
Cholesterol Transport and 
Morphogen Signaling
The molecular details of how choles-
terol exits lysosomes and is integrated 
into cellular and endoplasmic reticulum 
membranes remain unclear. Two pro-
teins implicated in this exit process, the 
13-transmembrane transporter NPC1 
and secreted NPC2, are known to be 
mutated in Niemann-Pick type C (NPC) 
disease in humans, characterized by 
cholesterol accumulation. A recent X-ray 
crystallographic study in Cell (Kwon 
et al., 2009) proposes an ingenious 
“hand-off” mechanism between the 
cholesterol-scavenging NPC2 protein 
and the membrane-bound NPC1. An 
immunoglobulin-like fold in NPC2 opens 
to “swallow” a cholesterol molecule; 
the new finding is that the extracellular 
N-terminal domain of NPC1 has a heli-
cal structure that can also sequester 
cholesterol, but in an orientation oppo-
site to that of NPC2. Neatly, a pocket-to-
pocket interaction between cholesterol-
loaded NPC2 and NPC1 may move the 
cholesterol to the N-terminal domain, 
which is only a short pivot away from the 
transporter core of NPC1, enabling sub-
sequent integration into the lysosomal 
membrane (Kwon et al., 2009).
Using fold-recognition methods, we 
earlier predicted that the N-terminal 
cysteine-rich domain of Hedgehog-
interacting protein 1 (HHIP1) has a 
Frizzled domain (FZD) fold (Bosanac et 
al., 2009). We have now used HHpred 
(Söding, 2005) to search the human 
proteome with a sequence profile 
derived from the HHIP1 alignment and 
have detected a distant but compelling 
sequence relationship to cysteine-rich 
modules of NPC1 and folate receptors 
(Supplemental Data available online); 
by transitivity, these latter domains 
should also share the FZD fold of 
HHIP1. These findings prompted us to 
make a detailed structural comparison 
between the cholesterol-bound N-ter-
minal domain of human NPC1 (Kwon 
et al., 2009), the chicken riboflavin-
binding protein docked to riboflavin (RBP; a paralog of folate receptors) 
(Monaco, 1997), and the FZD module 
of the mouse Frz8 (Frizzled) receptor 
(Dann et al., 2001). The Dali program 
for superimposing protein structures 
(Holm et al., 2008) reveals a highly sig-
nificant structural homology between 
the similar length chains of NPC1 and 
RBP (224 and 212 amino acids, respec-
tively; Z score = 7.6, rmsd = 3.7 Å over 
135 aligned residues with 20% iden-
tity). However, the shorter 121 residue 
Frz8 structure is a more distant match 
to NPC1 (Z score = 4.1, rmsd = 3.4 Å for 
96 aligned residues at 8% identity) and 
RBP (Z score = 2.0, rmsd = 4.2 Å with 
83 matched residues at 12% identity). 
The shared core domain comprises 
four helices (Figure 1B, helices B–E) 
in a splayed-open bundle; RBP has 
replaced the kinked B helices of NPC1 
and Frz8 with a hairpin loop. The over-
all low degree of sequence identity is 
offset by the striking concordance of 
cysteine residues that stitch together Cell 138, Sethe helical scaffolds with conserved 
disulfide bridges—most notably cap-
tured by CX8CX3,6C and CX3CX6C motifs 
in helices C and D, respectively (Figure 
S1).
This fold superimposition places cho-
lesterol bound to NPC1 and riboflavin 
bound to RBP in the same topographic 
location, a protected binding pocket 
formed by the core helices (Figure 1). 
Both NPC1 and RBP use similar amino 
acids to line these binding cavities and 
differ only in the nature of the protective 
protein “flaps” that overlay the entrance 
to the pocket. For instance, NPC1 and 
RBP have β strand hairpins that respec-
tively branch out between helices C 
and D or D and E (Figures 1 and S1). By 
contrast, the Frz8 structure is empty, 
though we can infer a homologous con-
stellation of hydrophobic and aromatic 
residues that might play a role in binding 
of a sterol-like or lipid-like ligand if the 
packing of the FZD domain core helices 
is slightly relaxed (Figure S1). The com-
pact FZD fold does not afford the large 
flaps that clamp down on bound ligands 
in NPC1 and RBP and instead appears 
more open.
Both Hedgehog (Hh) and Wnt ligands 
are lipid-modified morphogens. Hh is 
covalently tagged with cholesterol at its 
C-terminal end and with a palmitoyl group Figure 1. A Conserved Protein Fold Governs Sterol, Folate, and Lipid Binding in Frizzled-
Related Proteins
(A) Structural superimposition of the NPC1 N-terminal domain (PDB ID 3GKI), riboflavin-binding protein 
(RBP), and the Frizzled domain (FZD) of the Frz8 receptor (PDB ID 1IJY) highlights five core helices in a 
similar chain topology (colored from blue, N-terminal, to orange, C-terminal). A cyan loop hairpin in RBP 
replaces the cyan helices in NPC1 and in Frz8. Conserved disulfide bridges (Figure S1) appear in red stick 
form. Bound ligands (depicted as space-filling spheres) include cholesterol for NPC1 and riboflavin for 
RBP; the corresponding FZD pocket is empty. Distinct protein flaps (red) regulate access to the ligand 
pocket for NPC1 and RBP. Loop embellishments are in white. 
(B) The core fold has five helices labeled A (blue) through E (orange) with conserved disulfide bridges 
drawn as red lightening bolts. Alternative flap locations (numbered 1–3) across the different structures are 
indicated by red hairpin loops (Figure S1). The ligand-binding pocket is marked by a gray oval. 
(C) The compact helical fold of a moth pheromone-binding protein (PBP; PDB ID 1DQE) resembles the 
minimal helical core and similarly docks a hydrophobic bombykol molecule in the ligand pocket. The flap 
is formed by a helix hairpin.ptember 18, 2009 ©2009 Elsevier Inc. 1055
on an N-terminal cysteine. Wnt ligands 
have at least two palmitoylated residues. 
The FZD module is a hallmark of both Hh 
and Wnt signaling pathways, forming the 
essential Wnt-binding N-terminal domain 
in Frizzled serpentine receptors and reg-
ulating signaling by the Frizzled-related 
receptor Smoothened (Smo) in response 
to Hh binding to the Patched (Ptc) trans-
porter (Aanstad et al., 2009). A flap-free 
sterol-binding fold in the FZD module sug-
gests that it may be used to sequester the 
lipid tags of Hh and Wnt, while retaining a 
ring of protein contacts to the docked mor-
phogen. A chromophore-binding blue pig-
ment protein in jellyfish (Bulina et al., 2004) 
is entirely composed of a FZD module that 
has recouped its flaps (with an inserted 
kringle module between helices D and E).
In the active Wnt signaling complex, 
an LDL-receptor-related protein (LRP) 
coreceptor likely grips a protein end of 
the bridging Wnt, while the FZD N-termi-
nal domain of the Frizzled receptor might 
engage its palmitoyl groups (Figure S1). 
By contrast, soluble Frizzled-related 
proteins (sFRPs) could inhibit Wnt bind-
ing by capturing Wnt's lipid tags; the 
secreted Wnt-inhibitory factor (WIF) has 
an NPC2-like immunoglobulin fold and 
could similarly arrest Wnts. These per-
ceived inhibitory factors could also serve 
as intercellular Wnt shuttles by solubiliz-
ing the hydrophobic morphogen. If lipid 
docking by FZD or WIF-like modules is a 
requirement of Wnt-interacting proteins, 
then it is not surprising to find that other 
receptors that bind to Wnts like the Ror 
and MuSK tyrosine kinases also possess 
FZD domains; likewise, the Ryk receptor 
has a WIF-related ectodomain. The Hh 
morphogen does not interact directly 
with Smo, and instead its lipid tags have 
drawn it to Ptc, a distant relative of both 
NPC1 and 12-transmembrane sterol-like 
transporters (Hausmann et al., 2009). 
This binding has acquired a strong 
protein-protein component: a groove in 
Hh is suggested to critically engage a 
loop epitope in Ptc, a tactic co-opted 
by the β-propeller domain of the HHIP1 
decoy receptor (Bosanac et al., 2009). In 1056 Cell 138, September 18, 2009 ©2009 Ethe absence of Hh, Ptc transport of an 
unidentified lipophilic ligand may cata-
lytically repress Smo signaling by pump-
ing out a Smo antagonist, or by removing 
a Smo agonist (Hausmann et al., 2009). 
In either model, Hh binding would inhibit 
Ptc and a derepressed Smo could traf-
fic to the primary cilium and engage its 
signaling machinery. The structure of a 
natural Smo antagonist, cyclopamine, 
suggests that the receptor ligands (and 
Ptc cargo) are related to sterols. Other 
synthetic agonists and antagonists are 
aimed at the canonical binding cav-
ity in the center of Smo's GPCR-like 
bundle. Our model suggests that the 
N-terminal FZD domain of Smo provides 
a second sterol recognition pocket that 
may have a hand-off role analogous to 
the N-terminal domain of NPC1; alter-
natively, the communication between 
Smo pockets could be allosteric, with a 
“sterol-loaded” FZD module acting as an 
effector of the GPCR pocket (Figure S1). 
A two-state mechanism for Smo activa-
tion, perhaps involving the FZD module, 
has experimental support (Aanstad et 
al., 2009). This simpler mode of action, 
with Smo responding to a sterol trigger 
without explicit morphogen contact, may 
be closer to the ancestral function of the 
Frizzled receptor family.
Clues to the provenance of the FZD 
fold may lie in a class of small insect 
pheromone-binding and odorant-binding 
proteins that deliver hydrophobic or vola-
tile compounds to membrane signaling 
receptors (Tegoni et al., 2004). The helical 
folds of these cysteine-rich proteins have 
a core topology that resembles the helix 
B–E bundle of the FZD structure with a 
reduced set of disulfide bridges and simi-
lar contact residues in the ligand-binding 
pocket (Figures 1 and S1). Although not 
sufficient to conclude an evolutionary 
relationship, there are intriguing structural 
and mechanistic parallels. Pheromone-
binding proteins flex open to allow phero-
mone entry, a structural change harnessed 
to receptor activation as demonstrated by 
LUSH, a Drosophila odorant-binding pro-
tein, where only the pheromone-bound lsevier Inc.form can trigger a neuronal serpentine 
receptor (Laughlin et al., 2008). We pro-
pose that FZD-like modules are a vestige 
of an ancient chemosensory system that 
is still operational in the trafficking of cho-
lesterol and folate and in Hh and Wnt sig-
naling networks, acting as stealthy effec-
tors of signaling receptors.
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Supplemental Data include Supplemental Ex-
perimental Procedures and one figure and can be 
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